The bone marrow microenvironment contains a heterogeneous population of stromal cells organized into niches that support hematopoietic stem cells (HSCs) and other lineagecommitted hematopoietic progenitors. The stem cell niche generates signals that regulate HSC self-renewal, quiescence, and differentiation. Here, we review recent studies that highlight the heterogeneity of the stromal cells that comprise stem cell niches and the complexity of the signals that they generate. We highlight emerging data that stem cell niches in the bone marrow are not static but instead responsive to environmental stimuli. Finally, we review recent data showing that hematopoietic niches are altered in certain hematopoietic malignancies, and we discuss how these alterations might contribute to disease pathogenesis.
Initial studies using labeled HSC-enriched cell populations transplanted into recipients suggested a mostly endosteal location for HSCs. [15] [16] [17] However, more recent studies suggest that the majority of HSCs are perivascular and enriched in the highly vascular endosteal region. 12, 18 This region contains a complex network of stromal cells that have been implicated in HSC maintenance including osteolineage cells, endothelial cells (both arteriolar and venous), pericytes, CXCL12-abundant reticular (CAR) cells, sympathetic nerves, and non-myelinating Schwann cells. Recent evidence supports the presence of two stem cell niches in the bone marrow: the arteriolar niche and the sinusoidal-megakaryocyte niche ( Figure 1 ). Here, we briefly review these niches separately, although whether they are truly distinct niches is currently unclear. Of note, both the arteriolar and sinusoidal-megakaryocyte niches localize to the endosteal region, placing osteolineage cells in/near these niches. However, it is clear that a subset of HSCs is located in the central marrow. 19, 20 Indeed, Sean Morrison's recently reported that HSCs were more common in the central marrow than near bone surfaces. 20 Of note, in this study, HSCs were identified using transgenic mice that express GFP under control of the Ctnnal1 gene. Clearly, much of the controversy in the field may be due to the different experimental approaches used to localize HSCs in the bone marrow, as carefully reviewed elsewhere. 21 It will be important to determine if there are functional differences in HSCs that localize to these different niches. It is also worth noting that many of the key niche factors that regulate HSCs (e.g., CXCL12, stem cell factor, and TGF-β) are produced by several stromal cell populations. Thus, there may be a degree of functional redundancy between the various stromal cell populations in their support of HSCs.
Arteriolar niche. Paul Frenette's group showed that quiescent HSCs preferentially localize to arterioles in the endosteal region. 22 At its core, the arteriolar niche is comprised of endothelial cells and Nestin-GFP bright NG2 + arteriolar pericytes, both of which regulate HSCs.
Bone marrow endothelial cell expression of stem cell factor (SCF), 23 CXCL12, 24, 25 and Eselectin 26 contribute to HSC maintenance, and regeneration of sinusoidal endothelial cells is required for hematopoietic recovery from myeloablation. 27, 28 Arteriolar pericytes express high levels of the niche factors CXCL12 and SCF, and conditional ablation of NG2+ cells is associated with increased HSC cycling and a loss of HSC repopulating activity. 22 Of note, fibroblastic colony-forming unit (CFU-F) activity, which is associated with mesenchymal stem activity, is enriched in the Nestin-GFP bright stromal cell population, 22 which is consistent with prior studies implicating mesenchymal stem cells in HSC maintenance. 25, 29 For personal use only. on October 4, 2017. by guest www.bloodjournal.org From Arterioles are decorated with sympathetic nerves and nonmyelinating Schwann cells, which have been reported to modulate HSC activity in the bone marrow. Sympathetic nerves regulate bone marrow stromal cell CXCL12 expression, thereby regulating HSC egress from the bone marrow. 30, 31 Non-myelinating Schwann cells are a major source of activated transforming growth factor beta (TGF-β) in the bone marrow, 32 which contributes to HSC quiescence.
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Sinusoidal-megakaryocyte niche. Two recent studies suggest the presence of a stem cell niche defined by megakaryocytes in venous sinusoids. 19, 34 Approximately 20% of phenotypic HSCs localize directly adjacent to megakaryocytes in mice. Megakaryocytes are intimately associated with bone marrow sinusoidal endothelium, extending cytoplasmic protrusions into the sinusoids to produce platelets. Conditional ablation of megakaryocytes results in increased HSCs and HSC cycling, and data suggest that megakaryocytes normally restrain HSC proliferation through production of CXCL4 and TGF-β. 19, 34 Conversely, megakaryocyte production of fibroblast growth factor-1 (FGF-1) is thought to play a key role in supporting HSC and osteoblast expansion recovery following myeloablative therapy. [34] [35] [36] Of note, the impact of the loss of HSC quiescence after megakaryocyte ablation on HSC selfrenewal is an important but currently unanswered question. The sinusoidal-megakaryocyte niche also contains sinusoidal pericytes. Sinusoidal pericytes are not well characterized but likely overlap considerably with several previously defined mesenchymal stromal cell populations, including CAR cells, leptin-receptor + stromal cells, and nestin-GFP + stromal cells, each of which has been implicated in HSC maintenance. 23, [37] [38] [39] [40] Osteolineage cells. The localization of HSCs to endosteal sites supported studies of the role of osteoblast lineage cells (which we will refer to as osteolineage cells) in the HSC niche.
Indeed, the skeleton is absolutely necessary for mammalian hematopoiesis, as is demonstrated by genetic studies where lack of osteoblastic differentiation blocks hematopoiesis.
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Osteolineage cells produce a number of cytokines implicated in HSC regulation, including G-CSF 42 , thrombopoietin 43, 44 , angiopoietin 1 11 and CXCL12. 45 Expansion of osteolineage cells through targeted activation of parathyroid hormone receptor 1 9 or through conditional inactivation of bone morphogenic protein receptor type 1A 10 is associated with an increase in HSCs. Conversely, conditional ablation of osteolineage cells is associated with a loss of HSCs in the bone marrow and extramedullary hematopoiesis.
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Despite these findings, the contribution of osteolineage cells, particularly mature osteoblasts, to HSC maintenance is controversial. In fact, a global increase in osteoblastic cells
is not sufficient to expand HSCs, since, for example, treatment of mice with the bone anabolic
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From agent, strontium, leads to osteoblastic expansion but has no effect on HSC number or function. 47 Conversely, in mice with chronic inflammatory arthritis, resulting in osteoblast suppression, HSCs are normal. 48 Finally, conditional deletion of Cxcl12 24, 25 or Kitl 23 from mature osteoblasts has no effect on HSCs. These apparently discrepant data may be due, at least in part, the heterogeneity of osteolineage cells. In particular, a recent study showed that more primitive osteolineage cells express higher levels of SCF and CXCL12 and support the longterm repopulating activity of HSCs better than more differentiated osteolineage cells. 49 Thus, current evidence suggests that immature osteolineage cells rather than mature osteoblasts are required for HSC maintenance. However, the fact remains that a subset of HSCs are periendosteal, and the question is still open whether osteoblasts may play role in the development of such niches or in their maintenance under specific conditions. Data also suggest that cells of the osteoblastic lineage may provide support for lymphopoiesis and lymphoid tissue function.
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52 Indeed, ablation of osteolineage cells suppresses B and T lymphopoiesis in mice. 50, 52 Moreover, depletion of the chemokine CXCL12 from osteolineage cells results in loss of lymphoid progenitors in the marrow. 24 Together, these studies suggest that osteolineage cells provide a specialized niche for lymphoid progenitors.
There also is evidence implicating osteocytes, which are differentiated osteolineage cells buried in compact and trabecular bone, in the regulation of hematopoiesis. Ablation of osteocytes results in impaired HSC mobilization from the bone marrow in response to G-CSF.
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Conversely, loss of Gsα in osteocytes results in enhanced myelopoiesis through increased local production of G-CSF. 54 Collectively, these data suggest that specific stages of osteoblast maturation may regulate distinct types of hematopoietic progenitors.
Physiological regulation of stem cell niches in the bone marrow
There are emerging data that stem cell niches in the bone marrow are not static but instead responsive to external cues. In this section, we highlight studies that describe alterations in stem cell niches in the bone marrow in response to physiological cues. 
Summary and Future Directions
There is compelling evidence that signals from the bone marrow microenvironment play a key role in the regulation of normal and malignant hematopoiesis. The ability of stromal cells in the bone marrow microenvironment to support hematopoiesis is dynamic and responsive to environmental cues such as inflammation and stress. Ongoing research to identify the signals that regulate bone marrow stromal cells may provide novel strategies to modulate hematopoiesis for therapeutic benefit. For example, a phase I trial of PTH to expand the stem cell niche and HSPCs prior to G-CSF treatment resulted in an acceptable level of HSPC mobilization in nearly 50% of patients who previously failed had a mobilization failure. 
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